Prescription opioids, intended for post-surgery utilization, often go unused and undisposed, leading to the nonmedical use of opioids that could have harmful consequences.
Prescription opioids, intended for post-surgery utilization, often go unused and undisposed, leading to the nonmedical use of opioids that could have harmful consequences.
A study recently published by JAMA Surgery used MEDLINE, EMBASE, and Cochrane Register of Controlled Trials to search for studies that evaluate opioid oversupply for adults following a surgical procedure. This oversupply, or primary outcome, was categorized as the number of patients with filled but unused opioid prescriptions or unfilled opioid prescriptions.
“Prescriptions may go unfilled for several reasons, including adequate pain control after surgery,” the authors wrote. There are also instances where patients fill the prescription, but do not finish the medication, “leading to a reservoir of pills that can potentially contribute to the nonmedical use of opioids.”
From the database search, the researchers found 6 studies that reported a total of 810 patients who experienced 7 different types of surgical procedures. Among all of the studies considered, 67% to 92% of patients reported not using their opioid prescription; among all opioid tablets obtained by surgical patients, 42% to 71% were unused.
The majority of patients stopped using or did not use opioids once their pain was controlled. However, 16% to 29% of patients had reported adverse effects that were a result of their opioid utilization.
The research also considered the safety of how patients were storing their unused opioids. Of the studies reviewed, 2 evaluated storage safety and found that 73% to 77% of patients reported that they did not store their opioids in locked storage containers. This ultimately can contribute to opioid use by those who were not prescribed the drug originally.
Additionally, all of the observed studies had reported low rates of anticipated or actual disposal, but, no study had reported the use of the FDA recommended disposal method in more than 9% of patients. This, again, demonstrating the lack of prevention for those without a medical need to have access to the drug.
“Postoperative prescription opioids often go unused, unlocked, and undisposed, suggesting an important reservoir of opioids contributing to nonmedical use of these products, which could cause injuries or even deaths,” the authors concluded.
Early Involvement Critical in Treating Immunotherapy-Induced Overlap Syndrome
April 19th 2024A series of case studies reveals the importance of early diagnosis and involvement of special teams of clinicians when dealing with potential cases of overlap syndrome, which encompasses myocarditis, myasthenia gravis, and immune checkpoint inhibitor–related myositis.
Read More
Real-World Study Reveals Key Insights Into DLBCL Treatment Patterns, Outcomes
April 18th 2024A recent study offers valuable insights into the characteristics, treatment patterns, and outcomes of diffuse large B-cell lymphoma (DLBCL) in patients across different lines of therapy, providing a look into the landscape of DLBCL management.
Read More
Pegcetacoplan for PNH More Cost-Effective Than Anti-C5 Monoclonal Antibodies
April 18th 2024A cost-utility analysis conducted from the perspective of the Italian health system found that pegcetacoplan was more effective and less costly than 2 complement 5 (C5) inhibitors for the treatment of paroxysmal nocturnal hemoglobinuria (PNH).
Read More